Holgate, S. T. et al. Asthma. Nat. Rev. Dis. Primers 1, 15025 (2015).
Deliu, M., Belgrave, D., Sperrin, M., Buchan, I. & Custovic, A. Asthma phenotypes in childhood. Expert Rev. Clin. Immunol. 13, 705–713 (2017).
Golebski, K. et al. Maitland-van der Zee AH, Vijverberg SJH: Childhood asthma in the new omics era: Challenges and perspectives. Curr. Opin. Allergy Clin. Immunol. 20, 155–161 (2020).
Licari, A. et al. Asthma endotyping and biomarkers in childhood asthma. Pediatr. Allergy Immunol. Pulmonol. 31, 44–55 (2018).
Rackemann, F. M. A working classification of asthma. Am. J. Med. 3, 601–606 (1947).
Conrad, L. A., Cabana, M. D. & Rastogi, D. Defining pediatric asthma: Phenotypes to endotypes and beyond. Pediatr. Res. 90, 45–51 (2021).
Ricciardolo, F. L. M. et al. Characterization of T2-low and T2-high asthma phenotypes in real-life. Biomedicines 9, 1 (2021).
Fitzpatrick, A. M., Chipps, B. E., Holguin, F. & Woodruff, P. G. T2-“Low” asthma: Overview and management strategies. J. Allergy Clin. Immunol. Pract. 8, 452–463 (2020).
Kuruvilla, M. E. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin. Rev. Allergy Immunol. 56, 219–233 (2019).
Baos, S. et al. Biomarkers associated with disease severity in allergic and nonallergic asthma. Mol. Immunol. 82, 34–45 (2017).
Froidure, A. et al. Asthma phenotypes and IgE responses. Eur. Respir. J. 47, 304–319 (2016).
Peters, S. P. Asthma phenotypes: Nonallergic (intrinsic) asthma. J. Allergy Clin. Immunol. Pract. 2, 650–652 (2014).
Raedler, D., Ballenberger, N., Klucker, E., Böck, A. & Otto, R. Identification of novel immune phenotypes for allergic and nonallergic childhood asthma. J. Allergy Clin. Immunol. 135, 81–91 (2015).
Qi, C., Xu, C. J. & Koppelman, G. H. The role of epigenetics in the development of childhood asthma. Expert Rev. Clin. Immunol. 15, 1287–1302 (2019).
Midyat, L. et al. MicroRNA expression profiling in children with different asthma phenotypes. Pediatr. Pulmonol. 51, 582–587 (2016).
Gomez, J. L. Epigenetics in asthma. Curr. Allergy Asthma Rep. 19, 56 (2019).
Heffler, E. et al. MicroRNA profiling in asthma: Potential biomarkers and therapeutic targets. Am. J. Respir. Cell Mol. Biol. 57, 642–650 (2017).
Panettieri, R. A. Jr. Neutrophilic and pauci-immune phenotypes in severe asthma. Immunol. Allergy Clin. N. Am. 36, 569–579 (2016).
Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary report 2007. J. Allergy Clin. Immunol. 120, S94–S138 (2007).
Hogan, A. D. & Bernstein, J. A. GINA updated 2019: Landmark changes recommended for asthma management. Ann. Allergy Asthma Immunol. 124, 311–313 (2020).
Lee, J. H. et al. Predictive characteristics to discriminate the longitudinal outcomes of childhood asthma: A retrospective program-based study. Pediatr Res. 1, 1 (2022).
Novak, N. & Bieber, T. Allergic and nonallergic forms of atopic diseases. J. Allergy Clin. Immunol. 112, 252–262 (2003).
Romanet-Manent, S., Charpin, D., Magnan, A., Lanteaume, A. & Vervloet, D. Allergic vs nonallergic asthma: What makes the difference?. Allergy 57, 607–613 (2002).
Motulsky, H., & Christopoulos, A. Fitting models to biological data using linear and nonlinear regression: A practical guide to curve fitting (Oxford University Press, 2004).
Kozomara, A. & Griffiths-Jones, S. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39, D152-157 (2011).
Ewels, P., Magnusson, M., Lundin, S. & Käller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047–3048 (2016).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587-d592 (2023).
Storey, J. D. The positive false discovery rate: A Bayesian interpretation and the q-value. Ann. Stat. 31, 2013–2035 (2003).
Zoratti, E. M. et al. Asthma phenotypes in inner-city children. J. Allergy Clin. Immunol. 138, 1016–1029 (2016).
Siroux, V. et al. Relationships of allergic sensitization, total immunoglobulin E and blood eosinophils to asthma severity in children of the EGEA Study. Clin. Exp. Allergy 33, 746–751 (2003).
Boudier, A. et al. Ten-year follow-up of cluster-based asthma phenotypes in adults: A pooled analysis of three cohorts. Am. J. Respir. Crit. Care Med. 188, 550–560 (2013).
Deliu, M. et al. Features of asthma which provide meaningful insights for understanding the disease heterogeneity. Clin. Exp. Allergy 48, 39–47 (2018).
Padem, N. & Saltoun, C. Classification of asthma. Allergy Asthma Proc. 40, 385–388 (2019).
Holgate, S. et al. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J. Allergy Clin. Immunol. 115, 459–465 (2005).
Virchow, Jr, J.C. Intrinsic asthma. Asthma Rhinitis 1355–1378 (2000).
Tsolakis, N. et al. The absence of serum IgE antibodies indicates non-type 2 disease in young asthmatics. Clin. Exp. Allergy 48, 722–730 (2018).
Gupta, R. et al. Intercellular communication between airway epithelial cells is mediated by exosome-like vesicles. Am. J. Respir. Cell Mol. Biol. 60, 209–220 (2019).
Batson, B., Radicioni, G., Haridass, P., Dang, H., Mieczkowski, P., Abdullah, L., & Kesimer, M. Airway Mucins In Response To Il13 In Normal And Severe Asthmatic Airways. In A35 SEVERE ASTHMA. American Thoracic Society, A1375–A1375 (2017).
Xu, L., Yi, M., Tan, Y., Yi, Z. & Zhang, Y. A comprehensive analysis of microRNAs as diagnostic biomarkers for asthma. Ther. Adv. Respir. Dis. 14, 1753466620981863 (2020).
Cañas, J. A. et al. MicroRNAs as potential regulators of immune response networks in asthma and chronic obstructive pulmonary disease. Front. Immunol. 11, 608666 (2020).
Zhang, X. et al. The role of miR-29c/B7-H3 axis in children with allergic asthma. J. Transl. Med. 16, 218 (2018).
Francisco-Garcia, A. S. et al. Small RNA species and microRNA profiles are altered in severe asthma nanovesicles from broncho alveolar lavage and associate with impaired lung function and inflammation. Noncoding RNA 5, 1 (2019).
Boudewijn, I. M. et al. A novel role for bronchial MicroRNAs and long noncoding RNAs in asthma remission. Am. J. Respir. Crit. Care Med. 202, 614–618 (2020).
Taka, S., Tzani-Tzanopoulou, P., Wanstall, H. & Papadopoulos, N. G. MicroRNAs in asthma and respiratory infections: Identifying common pathways. Allergy Asthma Immunol. Res. 12, 4–23 (2020).
Specjalski, K. & Jassem, E. MicroRNAs: Potential biomarkers and targets of therapy in allergic diseases?. Arch. Immunol. Ther. Exp. (Warsz) 67, 213–223 (2019).
Palomares, O. et al. Regulatory T cells and immune regulation of allergic diseases: Roles of IL-10 and TGF-β. Genes Immun. 15, 511–520 (2014).
Lin, A. A., Freeman, A. F. & Nutman, T. B. IL-10 indirectly downregulates IL-4-induced IgE production by human B cells. Immunohorizons 2, 398–406 (2018).
Sánchez-Guerrero, I. et al. Soluble CD23 (sCD23) serum levels and lymphocyte subpopulations in peripheral blood in rhinitis and extrinsic and intrinsic asthma. Allergy 49, 587–592 (1994).
Kawakami, T. & Blank, U. From IgE to omalizumab. J. Immunol. 197, 4187–4192 (2016).
Beckert, H., Meyer-Martin, H., Buhl, R., Taube, C. & Reuter, S. The canonical but not the noncanonical wnt pathway inhibits the development of allergic airway disease. J. Immunol. 201, 1855–1864 (2018).
Koopmans, T. & Gosens, R. Revisiting asthma therapeutics: Focus on WNT signal transduction. Drug. Discov. Today 23, 49–62 (2018).
Hachim, M. Y. et al. Wnt signaling is deranged in asthmatic bronchial epithelium and fibroblasts. Front. Cell Dev. Biol. 9, 1 (2021).
Kino, T., Su, Y. A. & Chrousos, G. P. Human glucocorticoid receptor isoform beta: Recent understanding of its potential implications in physiology and pathophysiology. Cell Mol. Life Sci. 66, 3435–3448 (2009).
Liu, Z. W., Yue, F., Gao, F. Y., Qian, Y. B. & Wang, R. L. Research on the molecular mechanism of Seretide treatment to asthma disease. Eur. Rev. Med. Pharmacol. Sci. 16, 1701–1706 (2012).
Misior, A.M. Regulation of airway smooth muscle proliferation: Cytokine-, glucocorticoid-, and PKA-dependent mechanisms (2008).
Weidner, J., Ekerljung, L., Malmhäll, C., Miron, N. & Rådinger, M. Circulating microRNAs correlate to clinical parameters in individuals with allergic and non-allergic asthma. Respir. Res. 21, 107 (2020).
Liang, Y. R. et al. Transcriptome analysis in patients with asthma after inhaled combination therapy with long-acting β2-agonists and corticosteroids. Int. J. Med. Sci. 19, 1770–1778 (2022).
Pembrey, L. et al. Understanding asthma phenotypes: The World Asthma Phenotypes (WASP) international collaboration. ERJ Open Res. 4, 1 (2018).